STRS Ohio’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.16M | Sell |
5,800
-300
| -5% | -$59.4K | ﹤0.01% | 677 |
|
|
2025
Q4 | $1.15M | Sell |
6,100
-400
| -6% | -$76.9K | ﹤0.01% | 662 |
|
|
2025
Q3 | $1.15M | Sell |
6,500
-900
| -12% | -$134K | ﹤0.01% | 649 |
|
|
2025
Q2 | $841K | Sell |
7,400
-100
| -1% | -$10.7K | ﹤0.01% | 984 |
|
|
2025
Q1 | $789K | Hold |
7,500
| – | – | ﹤0.01% | 964 |
|
|
2024
Q4 | $804K | Sell |
7,500
-600
| -7% | -$67.8K | ﹤0.01% | 932 |
|
|
2024
Q3 | $811K | Sell |
8,100
-700
| -8% | -$70.5K | ﹤0.01% | 986 |
|
|
2024
Q2 | $741K | Sell |
8,800
-500
| -5% | -$39.8K | ﹤0.01% | 994 |
|
|
2024
Q1 | $679K | Sell |
9,300
-1,700
| -15% | -$125K | ﹤0.01% | 1062 |
|
|
2023
Q4 | $785K | Sell |
11,000
-300
| -3% | -$17.7K | ﹤0.01% | 1005 |
|
|
2023
Q3 | $677K | Buy |
11,300
+1,500
| +15% | +$98.7K | ﹤0.01% | 1065 |
|
|
2023
Q2 | $706K | Hold |
9,800
| – | – | ﹤0.01% | 1078 |
|
|
2023
Q1 | $720K | Sell |
9,800
-1,200
| -11% | -$85.3K | ﹤0.01% | 1079 |
|
|
2022
Q4 | $734K | Sell |
11,000
-1,023
| -9% | -$66.5K | ﹤0.01% | 1087 |
|
|
2022
Q3 | $645K | Hold |
12,023
| – | – | ﹤0.01% | 1170 |
|
|
2022
Q2 | $669K | Buy |
12,023
+642
| +6% | +$36.4K | ﹤0.01% | 1173 |
|
|
2022
Q1 | $798K | Hold |
11,381
| – | – | ﹤0.01% | 1175 |
|
|
2021
Q4 | $1.1M | Hold |
11,381
| – | – | ﹤0.01% | 1069 |
|
|
2021
Q3 | $989K | Sell |
11,381
-2,725
| -19% | -$211K | ﹤0.01% | 1107 |
|
|
2021
Q2 | $1.15M | Buy |
14,106
+9,297
| +193% | +$773K | ﹤0.01% | 1087 |
|
|
2021
Q1 | $457K | Buy |
+4,809
| New | +$455K | ﹤0.01% | 1607 |
|
|
2019
Q3 | – | Sell |
-481
| Closed | -$34K | – | 2110 |
|
|
2019
Q2 | $34K | Sell |
481
-2,084
| -81% | -$153K | ﹤0.01% | 1976 |
|
|
2019
Q1 | $201K | Sell |
2,565
-78,066
| -97% | -$5.91M | ﹤0.01% | 1672 |
|
|
2018
Q4 | $6.83M | Buy |
80,631
+75,341
| +1,424% | +$8.03M | 0.03% | 396 |
|
|
2018
Q3 | $905K | Buy |
5,290
+1,122
| +27% | +$169K | ﹤0.01% | 934 |
|
|
2018
Q2 | $538K | Buy |
4,168
+481
| +13% | +$53.7K | ﹤0.01% | 1330 |
|
|
2018
Q1 | $379K | Buy |
3,687
+962
| +35% | +$95.1K | ﹤0.01% | 1385 |
|
|
2017
Q4 | $232K | Sell |
2,725
-30,778
| -92% | -$2.67M | ﹤0.01% | 1482 |
|
|
2017
Q3 | $2.85M | Buy |
33,503
+31,419
| +1,508% | +$2.49M | 0.01% | 579 |
|
|
2017
Q2 | $157K | Buy |
2,084
+1,443
| +225% | +$101K | ﹤0.01% | 1556 |
|
|
2017
Q1 | $42K | Hold |
641
| – | – | ﹤0.01% | 1788 |
|
|
2016
Q4 | $40K | Sell |
641
-802
| -56% | -$50.6K | ﹤0.01% | 1816 |
|
|
2016
Q3 | $91K | Sell |
1,443
-1,122
| -44% | -$82.4K | ﹤0.01% | 1696 |
|
|
2016
Q2 | $190K | Buy |
2,565
+1,603
| +167% | +$119K | ﹤0.01% | 1561 |
|
|
2016
Q1 | $64K | Sell |
962
-7,694
| -89% | -$468K | ﹤0.01% | 1741 |
|
|
2015
Q4 | $585K | Sell |
8,656
-10,099
| -54% | -$623K | ﹤0.01% | 1213 |
|
|
2015
Q3 | $1M | Buy |
+18,755
| New | +$1.14M | ﹤0.01% | 819 |
|
|
2015
Q1 | – | Sell |
-27,892
| Closed | -$1.07M | – | 1842 |
|
|
2014
Q4 | $926K | Sell |
27,892
-2,405
| -8% | -$78.2K | ﹤0.01% | 836 |
|
|
2014
Q3 | $888K | Buy |
30,297
+3,687
| +14% | +$122K | ﹤0.01% | 814 |
|
|
2014
Q2 | $1.03M | Buy |
26,610
+2,565
| +11% | +$104K | ﹤0.01% | 763 |
|
|
2014
Q1 | $1.01M | Sell |
24,045
-5,931
| -20% | -$247K | ﹤0.01% | 728 |
|
|
2013
Q4 | $984K | Buy |
29,976
+3,206
| +12% | +$104K | ﹤0.01% | 754 |
|
|
2013
Q3 | $723K | Buy |
+26,770
| New | +$753K | ﹤0.01% | 1062 |
|
Other funds holding LGND
VPM
VCM
NAMI
CC
STRS Ohio's LGND Position: Q1 2026 in Review
STRS Ohio reduced its Ligand Pharmaceuticals (LGND) stake by 4.9% in Q1 2026, selling an estimated $59.4K and leaving 5,800 shares worth $1.16M. The position accounts for ﹤0.01% of the portfolio, ranked #677.
STRS Ohio first reported a position in LGND in Q3 2013 and has held it in 43 quarters since. The position peaked at $6.83M in Q4 2018. 357 funds tracked by Wall St. Rank hold LGND as of Q1 2026.
- STRS Ohio held 5,800 shares of Ligand Pharmaceuticals worth $1.16M as of Q1 2026.
- STRS Ohio sold 300 Ligand Pharmaceuticals shares in Q1 2026, an estimated $59.4K.
- Ligand Pharmaceuticals made up ﹤0.01% of STRS Ohio's portfolio in Q1 2026, its #677 holding.
- STRS Ohio first reported a position in Ligand Pharmaceuticals in Q3 2013 and has held it in 43 quarters since.
- STRS Ohio's Ligand Pharmaceuticals position peaked at $6.83M in Q4 2018.
- 357 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2026.
Based on STRS Ohio's 13F filing for Q1 2026, filed 24 Apr 2026.